Rethinking risk-benefit assessment for phase I cancer trials.
Joffe
Steven
S
Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Miller
Franklin G
FG
D035843:Biomedical Research / Q000941:ethics; D017321:Clinical Trials, Phase I as Topic / Q000941:ethics*; D004992:Ethics, Medical; D006801:Humans; D009369:Neoplasms / Q000628:therapy; D012107:Research Design; D018570:Risk Assessment